CJC-1295 DAC
CJC-1295 DAC is an albumin-binding, long-acting variant of Modified GRF (1-29): the same growth-hormone-releasing-hormone backbone as the no-DAC form, extended at Lys30 with an Nε-3-maleimidopropionyl Drug Affinity Complex (DAC) linker.

Identity & structure
Primary sequence · 30 residues · C-terminal amide · Mod-GRF(1-29) backbone (D-Ala2 · Gln8 · Ala15 · Nle27) extended by Lys30, whose ε-amine carries the 3-maleimidopropionyl DAC linker — the maleimide is not expressible as a residue and is not shown.
| Identity | |
|---|---|
| CAS | 446262-90-4 |
| PubChem CID | 91971820 |
| FDA UNII | 62RC32V9N7 |
| Also known as | CJC-1295 with DAC, CJC 1295 DAC, CJC-1295 DAC, DAC:GRF, CJC-1295 DAC peptide |
| Research class | Secretagogue & Regulatory |
| Structure | |
| Molecular formula | C165H269N47O46 |
| InChIKey | ZUQGTWKGESAQCD-ZGFIGYLBSA-N |
| Sequence | Mod GRF (1-29) backbone + Lys30 (Nε-3-maleimidopropionyl DAC linker) |
| Length | 30 residues |
| Analytical | |
| Average molecular weight | 3647.20 g/mol |
| Monoisotopic mass | 3645.0155 Da (computed) |
The 29-residue Modified GRF (1-29) backbone (as in the no-DAC form) extended by a 30th residue, Lys30, whose ε-amine carries a 3-maleimidopropionyl "Drug Affinity Complex" (DAC) group — an albumin-binding linker. The maleimide is not expressible in a plain single-letter sequence string.
Disambiguation
CJC-1295 DAC is an albumin-binding, long-acting variant of Modified GRF (1-29): the same growth-hormone-releasing-hormone backbone as the no-DAC form, extended at Lys30 with an Nε-3-maleimidopropionyl Drug Affinity Complex (DAC) linker. It is listed here strictly as an analytical reference and disambiguation entry — it is not sold, stocked, or certified by Lineará, and has no price or certificate of analysis. The data on this page is characterization only: molecular formula C165H269N47O46 and the values computed from it. It is a distinct chemical form from CJC-1295 (no DAC), which Lineará stocks and characterizes separately.
Not to be confused with CJC-1295 (no DAC). Albumin-binding long-acting variant of Modified GRF (1-29). The compound Lineará stocks is the no-DAC form (CJC-1295 / Mod GRF 1-29); this DAC variant is listed here for characterization and disambiguation only. Listed solely as a characterized analytical reference — no representation is made as to any biological effect. For Research Use Only — not for human or veterinary use.
How CJC-1295 DAC is characterized
Identity rests on the molecular formula and mass. Electrospray mass spectrometry (ESI-MS) measures the mass-to-charge ratio of the intact molecule; the average and monoisotopic masses are computed from the verified formula and cross-check the composition. The residue sequence and the modifications noted above define the structure.
Frequently asked questions
What is CJC-1295 DAC?
What is the molecular formula of CJC-1295 DAC?
What is the CAS number of CJC-1295 DAC?
Is CJC-1295 DAC the same as CJC-1295 (no DAC)?
Is CJC-1295 DAC a peptide?
How is CJC-1295 DAC stored and reconstituted?
Does Lineará sell CJC-1295 DAC?
Is CJC-1295 DAC approved for human use?
Data, tools & related references
References
- PubChem — compound identity, structure & computed properties (CID 91971820). PubChem →
- CAS Registry Number 446262-90-4.
- FDA Global Substance Registration System — UNII 62RC32V9N7.
- Stocked form: CJC-1295 (no DAC) — structure, CAS & molecular weight.
Research professionals only
Reference data
This monograph is characterization reference data. Lineará does not sell, stock, or certify CJC-1295 DAC.